Chemotherapeutic agents that are used to treat AML and that are ABCG2 substrates include mitoxantrone [60], topotecan [60], flavopiridol [61] and the nucleoside analogs cladribine, clofarabine and fludarabine [62]. The gene discussed is ABCG2; the disease is acute myeloid leukemia.